PSYCH OpenIR  > 中国科学院心理健康重点实验室
Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders
Kong, Qingyan1,2; Han, Buxin1,2,3
第一作者Qingyan Kong
通讯作者邮箱[email protected] (buxin han)
心理所单位排序1
摘要

IntroductionAnxiety disorders are characterized by widespread and persistent anxiety or recurrent panic attacks. As a result of their high prevalence, chronicity, and comorbidity, patients' quality of life and functioning are severely compromised. However, several patients do not receive treatment.Areas coveredThis review discusses the effectiveness, safety, and limitations of major medications and cognitive bias modification (CBM) for treating anxiety disorders. The possibility of combined treatment is also discussed in the literature. Furthermore, drawing on Chinese cultural perspectives, the authors suggest that anxiety can be recognized, measured, and coped with at three levels of skill (), vision (), and Tao ().Expert opinionThe combination of pharmacotherapy and CBM is possibly more effective in treating anxiety disorders than either treatment alone. However, clinicians and patients should participate in the joint decision-making process and consider comprehensive factors. Moderate anxiety has adaptive significance. In the coming years, by combining the downward analytical system of western culture with the upward integrative system of Chinese culture, a comprehensive understanding of anxiety and anxiety disorders should be established, rather than focusing only on their treatment.

关键词Anxiety disorders cognitive bias modification Chinese culture pharmacotherapy treatment
2024-05-03
语种英语
DOI10.1080/14737175.2024.2334847
发表期刊EXPERT REVIEW OF NEUROTHERAPEUTICS
ISSN1473-7175
卷号24期号:5页码:517-525
期刊论文类型综述
收录类别SCI
资助项目Social Science Foundation of China[20VYJ041]
出版者TAYLOR & FRANCIS LTD
WOS关键词SOCIAL ANXIETY ; PREGABALIN ; EFFICACY ; ATTENTION ; CARE ; COMORBIDITY ; FEAR ; PHARMACOLOGY ; PREVALENCE ; RECURRENCE
WOS研究方向Neurosciences & Neurology ; Pharmacology & Pharmacy
WOS类目Clinical Neurology ; Pharmacology & Pharmacy
WOS记录号WOS:001195013400001
WOS分区Q2
资助机构Social Science Foundation of China
引用统计
文献类型期刊论文
条目标识符http://ir.psych.ac.cn/handle/311026/47547
专题中国科学院心理健康重点实验室
通讯作者Han, Buxin
作者单位1.Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China
2.Univ Chinese Acad Sci, Dept Psychol, Beijing, Peoples R China
3.Chinese Acad Sci, Inst Psychol, 16 Lincui Rd, Beijing 100101, Peoples R China
第一作者单位中国科学院心理健康重点实验室
通讯作者单位中国科学院心理健康重点实验室;  中国科学院心理研究所
推荐引用方式
GB/T 7714
Kong, Qingyan,Han, Buxin. Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS,2024,24(5):517-525.
APA Kong, Qingyan,&Han, Buxin.(2024).Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders.EXPERT REVIEW OF NEUROTHERAPEUTICS,24(5),517-525.
MLA Kong, Qingyan,et al."Pharmacotherapy and cognitive bias modification for the treatment of anxiety disorders".EXPERT REVIEW OF NEUROTHERAPEUTICS 24.5(2024):517-525.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Pharmacotherapy and (759KB)期刊论文出版稿限制开放CC BY-NC-SA请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Kong, Qingyan]的文章
[Han, Buxin]的文章
百度学术
百度学术中相似的文章
[Kong, Qingyan]的文章
[Han, Buxin]的文章
必应学术
必应学术中相似的文章
[Kong, Qingyan]的文章
[Han, Buxin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。